ViiV Healthcare Company;Janssen Sciences Ireland Unlimited Company
发明人:
申请号：
IL27198720
公开号：
IL271987D0
申请日:
2020.01.12
申请国别(地区):
IL
年份:
2020
代理人:
摘要：
A method of treating HIV comprising intramuscular administration once every 4 weeks or less frequently of a combination of cabotegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof, including the option of discontinuing administration of a first oral anti-retroviral regimen and intramuscularly administering, once four weeks or less often said combination of cabotegravir and rilpivirine.
